FIELD: medicine. SUBSTANCE: method involves adding 13-65 g of creatine (or 15-75 g of creatine hydrate) and 3.5-4.7 g of sodium chloride (to achieve 200-220 mMole concentration) before injecting radiopaque medium into the coronary arteries. EFFECT: enhanced effectiveness in preventing arrhythmia or cardiac function disorders due to coronography. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EXPERIMENTAL CORONAROGRAPHY METHOD | 1996 |
|
RU2127548C1 |
| METHOD OF EXPERIMENTAL CORONAROGRAPHY | 1992 |
|
RU2045961C1 |
| CORONAROGRAPHY PROCESS IN EXPERIMENT | 2006 |
|
RU2325112C2 |
| METHOD FOR PERFORMING CORONOGRAPHIC EXAMINATION IN EXPERIMENTS | 2006 |
|
RU2314813C2 |
| METHOD FOR CARRYING OUT CORONOGRAPHY UNDER EXPERIMENTAL CONDITION | 2006 |
|
RU2319446C2 |
| METHOD FOR CARRYING OUT CORONOGRAPHY UNDER EXPERIMENTAL CONDITION | 2006 |
|
RU2319447C2 |
| METHOD FOR RESTORING HEART CONTRACTILITY AFTER CARDIOPLEGIA WITH CALCIUM ANTAGONISTS IN EXPERIMENT | 1996 |
|
RU2133612C1 |
| METHOD FOR MODELING VENTRICLES FIBRILLATION IN EXPERIMENT | 2006 |
|
RU2309464C1 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
| ANTIARRHYTHMIC PREPARATION | 1999 |
|
RU2185159C2 |
